Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Learn the key aspects of investment vehicles that every beginner should know. Equip yourself with the knowledge to make informed investment decisions.
21,493 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Chevron’s move to explore pipeline routes that bypass the Strait of Hormuz could change oil flows and stock risk prof...
Amazon and Shopify posted contrasting Q1 2026 results, underscoring a widening gap between a capital-heavy expansion ...
A single director's sale at MannKind raises questions about the durability of royalty streams. This analysis breaks d...
Two tech giants are racing to power AI at scale, pouring hundreds of billions into data centers and power. The big qu...
President Trump has nominated Kevin Warsh to chair the Federal Reserve, a move that could reshape U.S. monetary polic...
When a stock beats estimates but slides after hours, it creates a nagging question for investors. Here’s a clear, pra...
Novo Nordisk isn’t in the spotlight, but its steady cash flow and strong pipeline could unlock long-term gains. This ...
Markets can tumble fast in crypto, but a disciplined plan can uncover resilient opportunities. This crypto crash play...
Space-based connectivity is drawing attention to AST SpaceMobile. This article analyzes potential price trajectories,...
A new AI-powered marketing platform is offering shares at $0.85 in a Reg A+ round, drawing comparisons to early Nvidi...
U.S. equities rebounded on Feb 24, 2026, led by AI optimism and a landmark Meta-AMD pact. Traders see the love-hate t...